These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1808 related items for PubMed ID: 20528601

  • 1. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE, Noonan MJ.
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [Abstract] [Full Text] [Related]

  • 2. Budesonide/formoterol pressurized metered-dose inhaler for patients with persistent asthma.
    Korenblat PE, Rosenwasser LJ.
    Allergy Asthma Proc; 2010 May; 31(3):190-202. PubMed ID: 20482961
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
    Drugs; 2006 May; 66(17):2235-54. PubMed ID: 17137405
    [Abstract] [Full Text] [Related]

  • 4. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
    Corren J, Korenblat PE, Miller CJ, O'Brien CD, Mezzanotte WS.
    Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
    [Abstract] [Full Text] [Related]

  • 5. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler.
    Chervinsky P, Baker J, Bensch G, Parasuraman B, Boggs R, Martin P, O'Dowd L.
    Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199
    [Abstract] [Full Text] [Related]

  • 6. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
    Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O'Dowd L.
    Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.
    Tashkin DP, Rennard SI, Martin P, Ramachandran S, Martin UJ, Silkoff PE, Goldman M.
    Drugs; 2008 Mar; 68(14):1975-2000. PubMed ID: 18778120
    [Abstract] [Full Text] [Related]

  • 8. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S, Vogelmeier C, Buhl R.
    Med Klin (Munich); 2008 May 15; 103(5):299-310. PubMed ID: 18484216
    [Abstract] [Full Text] [Related]

  • 9. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
    Hampel FC, Martin P, Mezzanotte WS.
    J Asthma; 2008 May 15; 45(4):265-72. PubMed ID: 18446589
    [Abstract] [Full Text] [Related]

  • 10. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
    J Asthma; 2010 Mar 15; 47(2):217-23. PubMed ID: 20170333
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
    Kerwin EM, Oppenheimer JJ, LaForce C, Parasuraman B, Miller CJ, O'Dowd L, Goldman M.
    Ann Allergy Asthma Immunol; 2009 Jul 15; 103(1):62-72. PubMed ID: 19663129
    [Abstract] [Full Text] [Related]

  • 12. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
    Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M.
    J Allergy Clin Immunol; 2008 Jun 15; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
    Zangrilli J, Mansfield LE, Uryniak T, O'Brien CD.
    Ann Allergy Asthma Immunol; 2011 Sep 15; 107(3):258-65.e2. PubMed ID: 21875546
    [Abstract] [Full Text] [Related]

  • 14. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
    Tal A, Simon G, Vermeulen JH, Petru V, Cobos N, Everard ML, de Boeck K.
    Pediatr Pulmonol; 2002 Nov 15; 34(5):342-50. PubMed ID: 12357478
    [Abstract] [Full Text] [Related]

  • 15. Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler in adolescents and adults with asthma.
    Morice AH, Hochmuth L, Ekelund J, Thorén A, Puterman AS.
    Pulm Pharmacol Ther; 2008 Nov 15; 21(1):32-9. PubMed ID: 17118686
    [Abstract] [Full Text] [Related]

  • 16. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul 15; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
    Miller CJ, Senn S, Mezzanotte WS.
    Contemp Clin Trials; 2008 Mar 15; 29(2):114-24. PubMed ID: 17625985
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 91.